19/21.Sedexmethylphenidate and Dexmethyl phenidate (AZASTARYS)- (May 2021)- to treat attentn defecit hyperactivity disordr
Drug Name:
19/21.Sedexmethylphenidate and Dexmethyl phenidate (AZASTARYS)- (May 2021)- to treat attentn defecit hyperactivity disordr
List Of Brands:
Indication Type Description:
Indication:
BRIEF SUMMARY
SEDEXMETHYLPHENIDATE AND DEXAMETHYL PHENIDATE - (May 2021)
Indn-
Dosage-
ADR-
CI-
Pat Inform-
===================================================================
U.S. FDA APPROVED DRUGS SURING 2021
Serial No 19
Name of the Drug- AZSTARYS
Active Ingredient - Sedexmethylphenidate and Dexmethyl phenidate
Pharmacological Classification- To treat attention defecit hyperactivity disorder
Date of Approval- 3/18/2021
